The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
Get your brand in front of key decision-makers at the Cleanroom Technology Conference on 21 & 22 May 2025
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.